18595-35-2Relevant articles and documents
Synthesis of polylactide with thiol end groups
Popelka, Stepan,Rypacek, Frantisek
, p. 1131 - 1140 (2003)
Four synthetic routes to poly(L-lactide) with thiol end groups based on ring-opening polymerization of L-lactide (LA) catalysed with tin(II) 2-ethylhexanoate (Sn(Oct)2) are reported. The following alcohols were used as co-initiators of polymerization: 2-sulfanylethan-1-ol, 2-[(2,4-dinitrophenyl)sulfanyl]ethan-1-ol, 2-(tritylsulfanyl)ethan-1-ol and allyl alcohol. End groups introduced into polymers by co-initiators were transformed to thiol groups by a subsequent modification reaction. The efficiencies of the used synthetic methods were evaluated and discussed. The best results were obtained with co-initiator 2-(tritylsulfanyl)ethan-1-ol.
Shaltiel
, (1968)
Thiol-activated triplet-triplet annihilation upconversion: Study of the different quenching effect of electron acceptor on the singlet and triplet excited states of bodipy
Zhang, Caishun,Zhao, Jianzhang,Cui, Xiaoneng,Wu, Xueyan
, p. 5674 - 5686 (2015/06/16)
Thiol-activated triplet-triplet annihilation (TTA) upconversion was studied with two different approaches, i.e., with 2,4-dinitrobenzenenesulfonyl (DNBS)-caged diiodoBodipy triplet photosensitizers (perylene as the triplet acceptor/emitter of the upconver
THIOL MEDIATED/ACTIVATED PRODRUGS OF SULFUR DIOXIDE (SO2) HAVING ANTI-BACTERIAL ACTIVITY
-
Paragraph 0028, (2014/05/08)
Disclosed herein are thiol mediated/activated prodrugs of SO2, particularly 2,4-dinitrophenylsulfonamide analogues, having Formula-I or pharmaceutically acceptable salts thereof exhibiting tunable release profiles of SO2 with significant therapeutic efficacy against bacterial infections. Further, the present invention provides pharmaceutical compositions comprising compound of Formula I or pharmaceutically acceptable salts thereof, along with pharmaceutically acceptable carriers/excipients.